Vaccines, Blood & Biologics
12/04/2008 Telecon - RiaSTAP
RECORD OF TELEPHONE CONVERSATION
Submission Type: Original Application Submission ID: 125317/0 Office: OBRR
Product:
Human Fibrinogen Concentrate, Pasteurized
Applicant:
CSL Behring GmbH
Telecon Date/Time: 04-DEC-2008 12:00 AM Initiated by FDA? Yes
Telephone Number:
Communication Categorie(s):
Other
Author: VASANTHA KUMAR
Telecon Summary:
Discussions on post marketing study BI3023_3001 and BPAC administrative clarifications
FDA Participants: Nisha Jain, Basil Golding and Jennifer Scharpf
Non-FDA Participants: CSLB
Trans-BLA Group: No
Related STNs: None
Related PMCs: None
Telecon Body:
Discussions on post marketing study BI3023_3001 and BPAC administrative clarifications







